Replies to post #115763 on Biotech Values

[zipjet]

I would assume there would be an appeal, and that if Teva lost they would go for an injunction if m-copaxone was approved while the appeal was pending.

The losing party will appeal - too much at stake.

I think we can say that IF TEVA were to lose the patent case (invalidation of Copaxone patents or a finding that mC did NOT infringe) that there could be no injunction.

Of course there are some lawyers here that are more skilled than I am. So they can correct me if I have this wrong.

ij